PYC Therapeutics

About:

PYC Therapeutics (ASX: PYC) is a development-stage biotechnology company pioneering a new generation of RNA therapeutics

Website: http://www.pyctx.com/

Description:

Total Funding Amount:

40M AUD

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Nedlands, Western Australia, Australia

Founded Date:

2005-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2024-03-14

IPO Status:

Public

Industries:

© 2025 bioDAO.ai